David Shibata
Overview
Explore the profile of David Shibata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
191
Citations
5787
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Viskochil R, Lin T, Gigic B, Himbert C, Bandera V, Skender S, et al.
J Cancer Surviv
. 2025 Feb;
PMID: 39985691
Purpose: Physical activity plays key roles in colorectal cancer survivorship; however, the impact of different clinicodemographic outcomes on cross-sectional and longitudinal objectively measured physical activity 12 and 24 months post-diagnosis...
2.
Byrd D, Damerell V, Gomez Morales M, Hogue S, Lin T, Ose J, et al.
Int J Cancer
. 2025 Jan;
PMID: 39887373
Colorectal cancer (CRC) is the second overall leading cause of cancer death in the United States, with recurrence being a frequent cause of mortality. Approaches to improve disease-free survival (DFS)...
3.
Hodan R, Gupta S, Weiss J, Axell L, Burke C, Chen L, et al.
J Natl Compr Canc Netw
. 2024 Dec;
22(10):695-711.
PMID: 39689429
Multigene panel testing has allowed for the detection of a growing number of inherited pathogenic/likely pathogenic variants in people at high risk of cancer, including endometrial cancer (EC). Hereditary syndromes...
4.
Smith K, Gudenkauf L, Hoogland A, Li X, Hoobler R, Playdon M, et al.
Nutrients
. 2024 Nov;
16(22).
PMID: 39599646
Purpose: To characterize dietary patterns and examine associations with cross-sectional and longitudinal changes in quality of life (QOL) over approximately one year after colorectal cancer (CRC) diagnosis. Methods: The ColoCare...
5.
Ilozumba M, Lin T, Hardikar S, Byrd D, Round J, Stephens W, et al.
Cancer Med
. 2024 Nov;
13(22):e70431.
PMID: 39587707
Background: Cachexia accounts for about 20% of all cancer-related deaths and indicates poor prognosis. The impact of Fusobacterium nucleatum (Fn), a microbial risk factor for colorectal cancer (CRC), on the...
6.
Lorona N, Himbert C, Ose J, Cohen S, Strehli I, Ulrich C, et al.
Cancer Epidemiol Biomarkers Prev
. 2024 Oct;
34(1):59-66.
PMID: 39373623
Background: Findings from studies investigating the impacts of alcohol use and smoking on colorectal cancer outcomes are inconclusive. This study aimed to investigate associations between alcohol use and smoking status...
7.
Damerell V, Klaassen-Dekker N, Brezina S, Ose J, Ulvik A, van Roekel E, et al.
Int J Cancer
. 2024 Sep;
156(3):552-565.
PMID: 39308420
Alterations within the tryptophan-kynurenine metabolic pathway have been linked to the etiology of colorectal cancer (CRC), but the relevance of this pathway for prognostic outcomes in CRC patients needs further...
8.
Fleming A, Gehle D, Freitas J, Hendrick L, Yakoub D, Abdelhafeez H, et al.
J Surg Oncol
. 2024 Aug;
130(5):1051-1061.
PMID: 39155692
Background And Objectives: Solid pseudopapillary neoplasm (SPN) of the pancreas demonstrates an indolent disease course; however, some patients present with a "malignant" phenotype, including distant metastases resistant to chemotherapy. This...
9.
Benson A, Venook A, Adam M, Chang G, Chen Y, Ciombor K, et al.
J Natl Compr Canc Netw
. 2024 Aug;
22(6):366-375.
PMID: 39151454
The determination of an optimal treatment plan for an individual patient with rectal cancer is a complex process. In addition to decisions relating to the intent of rectal cancer surgery...
10.
Wright M, Shibata D
JCO Oncol Pract
. 2024 Aug;
20(12):1535-1537.
PMID: 39137383
Patients with young-onset colorectal cancer have unique challenges that require a multidisciplinary approach.